इंडस्ट्रीज
Showing 91–100 का 134 results
-
Melatonin (E-Pharmacy) चीन में बाज़ार
USD 5According to StrategyHelix, the melatonin (e-pharmacy) market in China is poised to grow at a CAGR of around 7.6% के विश्लेषण अवधि के दौरान 2021 को 2027.
-
AI (Artificial Intelligence) Medical Imaging Market in China
USD 5A statistic by StrategyHelix indicates that the AI (artificial intelligence) medical imaging market in China is expected to increase by US$ 4,299 मिलियन से 2021 को 2027, का सीएजीआर जुटाना 80.5% पूर्वानुमान अवधि के दौरान.
-
Cosmetic Contact Lenses Market in China
USD 10According to a statistic by StrategyHelix, the cosmetic contact lenses market in China is set to increase by US$ 6,253 के दौरान मिलियन 2021-2027, growing at a CAGR of 16% पूर्वानुमान अवधि के दौरान.
-
Makeup Market in China
USD 5In China, following a significant (36.3%) rise in 2019, makeup market in terms of revenue declined slightly (-0.4%), reaching 11,398 million USD in 2020, according to StrategyHelix.
-
Pharmaceutical Packaging Market in China
USD 5The pharmaceutical packaging market in China was around 17 billion USD in 2019, reached 18 billion USD in 2020 (an increase of 6.5% year-on-year), according to StrategyHelix’ analysis.
-
Mouthwash Market in China
USD 5A statistic by StrategyHelix indicates that the mouthwash market in China is set to grow at a healthy compound annual growth rate (सीएजीआर) का 9.2% अगले पांच वर्षों में.
-
Oral Care Market in China
USD 15According to a statistic by StrategyHelix, the oral care market in China is anticipated to expand positively at a CAGR of 14.3% पूर्वानुमान अवधि के दौरान (2021-2027).
-
Global Oral Care Market
USD 5The global oral care market is set to grow at a healthy compound annual growth rate (सीएजीआर) का 4.1% अगले पांच वर्षों में.
-
Primary Hypertension Drug Market in China
USD 10The primary hypertension drug market in China is poised to grow at a CAGR of around 8.9% के विश्लेषण अवधि के दौरान 2021 को 2027, according to StrategyHelix.
-
Global APIs (Active Pharmaceutical Ingredients) Market
USD 5Following a mild (5.9%) rise in 2019, the global APIs (active pharmaceutical ingredients) market in terms of revenue declined dramatically (-6.8%), reaching 163 billion USD in 2020, according to StrategyHelix.
